Lineage Cell Therapeutics, Inc. (LCTX)
1.50
0.00 (0.00%)
USD |
NYAM |
Mar 19, 13:54
Lineage Cell Therapeutics Total Liabilities (Quarterly) : 69.24M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pacira Biosciences, Inc. | 571.81M |
| OptimizeRx Corp. | 48.62M |
| Nutex Health, Inc. | 570.81M |
| ProKidney Corp. | 33.27M |
| Prime Medicine, Inc. | 495.77M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 112.58M |
| Shareholders Equity (Quarterly) | 44.55M |
| Debt to Equity Ratio | 0.0543 |
| Current Ratio | 5.204 |
| Net Debt Paydown Yield | 0.02% |